Your browser doesn't support javascript.
loading
Prevalence and associated risk factors for hepatitis B and C viruses among refugee populations living in Mahama, Rwanda: A cross-sectional study.
Kamali, Innocent; Barnhart, Dale A; Ndahimana, Jean d'Amour; Noor, Kassim; Mumporeze, Jeanne; Nyirahabihirwe, Françoise; Gakuru, Jean de la Paix; Musafiri, Tumusime; Urusaro, Sandra; Makuza, Jean Damascene; Serumondo, Janvier; Rwamuhinda, Dina Denis; Nkundibiza, Maurice; Kateera, Fredrick; Nshogoza, Gallican Rwibasira; Mubiligi, Joel M.
Affiliation
  • Kamali I; Partners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
  • Barnhart DA; Partners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
  • Ndahimana JD; Harvard Medical School, Department of Global Health and Social Medicine, Boston, Massachusetts, United States of America.
  • Noor K; Partners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
  • Mumporeze J; United Nations High Commissioner for Refugees (UNHCR), Kigali, Rwanda.
  • Nyirahabihirwe F; United Nations High Commissioner for Refugees (UNHCR), Kigali, Rwanda.
  • Gakuru JP; Partners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
  • Musafiri T; Partners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
  • Urusaro S; Partners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
  • Makuza JD; Partners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
  • Serumondo J; Rwanda Biomedical Centre, HIV/AIDS, STIs and OBBI Division, Kigali, Rwanda.
  • Rwamuhinda DD; University of British Columbia, School of Population and Public Health, Vancouver, British Columbia, Canada.
  • Nkundibiza M; Rwanda Biomedical Centre, HIV/AIDS, STIs and OBBI Division, Kigali, Rwanda.
  • Kateera F; Save the Children International, Kigali, Rwanda.
  • Nshogoza GR; Alight, Kigali, Rwanda.
  • Mubiligi JM; Partners In Health-Rwanda/Inshuti Mu Buzima, Rwinkwavu, Rwanda.
PLoS One ; 16(10): e0257917, 2021.
Article in En | MEDLINE | ID: mdl-34634039
INTRODUCTION: As part of the integration of refugees into Rwanda's national hepatitis C elimination agenda, a mass screening campaign for hepatitis B (HBV) and hepatitis C (HCV) was conducted among Burundian refugees living in Mahama Camp, Eastern Rwanda. This cross-sectional survey used data from the screening campaign to report on the epidemiology of viral hepatitis in this setting. METHODS: Rapid diagnostic tests (RDTs) were used to screen for hepatitis B surface antigen (HBsAg) and hepatitis C antibody (anti-HCV) among people of ≥15years old. We calculated seroprevalence for HBsAg and anti-HCV by age and sex and also calculated age-and-sex adjusted risk ratios (ARR) for other possible risk factors. RESULTS: Of the 26,498 screened refugees, 1,006 (3.8%) and 297 (1.1%) tested positive for HBsAg and Anti-HCV, respectively. HBsAg was more prevalent among men than women and most common among people 25-54 years old. Anti-HCV prevalence increased with age group with no difference between sexes. After adjusting for age and sex, having a household contact with HBsAg was associated with 1.59 times higher risk of having HBsAg (95% CI: 1.27, 1.99) and having a household contact with anti-HCV was associated with 3.66 times higher risk of Anti-HCV (95% CI: 2.26, 5.93). Self-reporting having HBV, HCV, liver disease, or previously screened for HBV and HCV were significantly associated with both HBsAg and anti-HCV, but RDT-confirmed HBsAg and anti-HCV statuses were not associated with each other. Other risk factors for HBsAg included diabetes (ARR = 1.97, 95% CI: 1.08, 3.59) and family history of hepatitis B (ARR = 1.32, 95% CI: 1.11, 1.56) and for anti-HCV included heart disease (ARR = 1.91, 95% CI: 1.30, 2.80) and history of surgery (ARR = 1.70, 95% CI: 1.24, 2.32). CONCLUSION: Sero-prevalence and risks factors for hepatitis B and C among Burundian were comparable to that in the Rwandan general population. Contact tracing among household members of identified HBsAg and anti-HCV infected case may be an effective approach to targeted hepatitis screening given the high risk among self-reported cases. Expanded access to voluntary testing may be needed to improve access to hepatitis treatment and care in other refugee settings.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Refugees / Hepatitis B virus / Hepatitis C / Hepacivirus / Hepatitis B Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2021 Document type: Article Affiliation country: Rwanda Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Refugees / Hepatitis B virus / Hepatitis C / Hepacivirus / Hepatitis B Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2021 Document type: Article Affiliation country: Rwanda Country of publication: United States